Six-month natural history of oral versus cervical human papillomavirus infection

被引:125
作者
D'Souza, Gypsyamber
Fakhry, Carole
Sugar, Elizabeth A.
Seaberg, Eric C.
Weber, Kathleen
Minkoff, Howard L.
Anastos, Kathryn
Palefsky, Joel M.
Gillison, Maura L.
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[2] Sidney Kimmel Comprehens Canc Ctr John Hopkins, Div Viral Oncol, Baltimore, MD USA
[3] Sidney Kimmel Comprehens Canc Ctr John Hopkins, Div Biometry & Clin Trials, Baltimore, MD USA
[4] John H Stroger Jr Hosp Cook Cty, CORE Ctr, Chicago, IL USA
[5] SUNY Downstate, Dept Obstet & Gynecol, Maimonides Med Ctr, Brooklyn, NY USA
[6] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA
[7] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
关键词
oral; HPV; natural history; comparison; cervical; human papillomavirus; infection;
D O I
10.1002/ijc.22667
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Human papillomavirus (HPV) infection is etiologically associated with a subset of oral cancers, and yet, the natural history of oral HPV infection remains unexplored. The feasibility of studying oral HPV natural history was evaluated by collecting oral rinse samples on 2 occasions at a 6-month interval from 136 HIV-positive and 63 HIV-negative participants. Cervical vaginal lavage samples were concurrently collected for comparison. HPV genomic DNA was detected in oral and cervical samples by consensus primer PCR and type-specified for 37 HPV types. The six-month cumulative prevalence of oral HPV infection was significantly less than for cervical infection (p < 0.0001). HIV-positive women were more likely than HIV-negative women to have an oral (33 vs. 15%, p = 0.016) or cervical (78 vs. 51%, p < 0.001) infection detected. Oral HPV infections detected at baseline were as likely as cervical infections to persist to 6 months among HIV-negative (60 % vs. 51 %, p = 0.70) and HIV-positive (55 % vs. 63 %, p = 0.27) women. Factors that independently elevated odds for oral HPV persistence differed from cervical infection and included current smoking (OR = 8, 95% CI = 1.3-53), age above 44 years (OR = 20, 95% CI = 4.1-83), CD4 < 500 (OR = 6, 95% CI = 1.1-26), use of HAART therapy (OR = 12, 95% CI = 1.0-156), and time on HAART therapy (trend p = 0.04). The rate of oral HPV infections newly detected at follow-up was significantly lower than cervical infection among HIV-positive (p < 0.001) and HIV-negative women (p < 0.001). Our study not only demonstrates that it is feasible to study the natural history of oral HPV infection with oral rinse sampling, but also indicates that oral and cervical HPV natural history may differ. (C) 2007 Wiley-Liss, Inc.
引用
收藏
页码:143 / 150
页数:8
相关论文
共 39 条
  • [1] Ahdieh L, 2000, AM J EPIDEMIOL, V151, P1148, DOI 10.1093/oxfordjournals.aje.a010165
  • [2] Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women
    Ahdieh, L
    Klein, RS
    Burk, R
    Cu-Uvin, S
    Schuman, P
    Duerr, A
    Safaeian, M
    Astemborski, J
    Daniel, R
    Shah, K
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (06) : 682 - 690
  • [3] The Women's Interagency HIV Study
    Barkan, SE
    Melnick, SL
    Preston-Martin, S
    Weber, K
    Kalish, LA
    Miotti, P
    Young, M
    Greenblatt, R
    Sacks, H
    Feldman, J
    [J]. EPIDEMIOLOGY, 1998, 9 (02) : 117 - 125
  • [4] The epidemiology of human papillomavirus infections
    Baseman, JG
    Koutsky, LA
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2005, 32 : S16 - S24
  • [5] The impact of highly active antiretroviral therapy and immunodeficiency on human papillomavirus infection of the oral cavity of human immunodeficiency virus-seropositive adults
    Cameron, JE
    Mercante, D
    O'Brien, M
    Gaffga, AM
    Leigh, JE
    Fidel, PL
    Hagensee, ME
    [J]. SEXUALLY TRANSMITTED DISEASES, 2005, 32 (11) : 703 - 709
  • [6] Concordance of prevalence of human papillomavirus DNA in anogenital and oral infections in a high-risk population
    Cañadas, MP
    Bosch, FX
    Junquera, ML
    Ejarque, M
    Font, R
    Ordoñez, E
    de Sanjosé, S
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (03) : 1330 - 1332
  • [7] Castle PE, 2002, JNCI-J NATL CANCER I, V94, P1406, DOI 10.1093/jnci/94.18.1406
  • [8] Risk factors for oral human papillomavirus in adults infected and not infected with human immunodeficiency virus
    Coutlee, F
    Trottier, AM
    Ghattas, G
    Leduc, R
    Toma, E
    Sanche, G
    Rodrigues, I
    Turmel, B
    Allaire, G
    Ghadirian, P
    [J]. SEXUALLY TRANSMITTED DISEASES, 1997, 24 (01) : 23 - 31
  • [9] Analysis of the effect of DNA purification on detection of human papillomavirus in oral rinse samples by PCR
    D'Souza, G
    Sugar, E
    Ruby, W
    Gravitt, P
    Gillison, M
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (11) : 5526 - 5535
  • [10] Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort
    Deacon, JM
    Evans, CD
    Yule, R
    Desai, M
    Binns, W
    Taylor, C
    Peto, J
    [J]. BRITISH JOURNAL OF CANCER, 2000, 83 (11) : 1565 - 1572